NON-FINAL ACTION - MAILED
final action
on 06 Dec 2024
Last Applicant/ Owned by
701 Lee Road, Suite 103
Wayne
PA
19087
Serial Number
98161571 filed on 01st Sep 2023
Registration Number
N/A
Correspondent Address
Michael A. Geller
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CONFLUENCE
Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology; drug discovery services; drug discovery consulting services; medical and scientific research consulting services in the field of drug discovery and pharmaceutical drug development; providing medical and scientific research, namely, as Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology; drug discovery services; drug discovery consulting services; medical and scientific research consulting services in the field of drug discovery and pharmaceutical drug development; providing medical and scientific research, namely, assay design and validation and biomarker assessment
First Use Date in General
03rd Aug 2017
First Use Date in Commerce
03rd Aug 2017
Mark Details
Serial Number
No 98161571
Mark Type
No Service Mark
Attorney Docket Number
No 396753.36
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Dec 2024 | NON-FINAL ACTION E-MAILED |
| 06th Dec 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 06th Dec 2024 | NON-FINAL ACTION WRITTEN |
| 12th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 12th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 12th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 26th Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 26th Aug 2024 | NON-FINAL ACTION E-MAILED |
| 26th Aug 2024 | NON-FINAL ACTION WRITTEN |
| 25th Aug 2024 | USE AMENDMENT ACCEPTED |